Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.0410
+0.0020
+(5.13%)
At close: February 28 at 1:32:49 PM GMT+1
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| Verrico (Christopher) Director of Issuer | Acquisition or disposition in the public market | Mar 11, 2024 | 1,574,539 |
| Verrico (Howard Jarman) Director of Issuer | Stock dividend | Oct 21, 2024 | 10,455,695 |
Related Tickers
IPH.PA Innate Pharma S.A.
2.1250
-3.63%
ACRV Acrivon Therapeutics, Inc.
5.31
-0.56%
QTTB Q32 Bio Inc.
2.2700
+1.34%
IOBT IO Biotech, Inc.
0.9450
-5.43%
ZYME Zymeworks Inc.
13.40
+0.45%
UCB.BR UCB SA
181.55
+0.72%
SRRK Scholar Rock Holding Corporation
38.82
+7.95%
PLRX Pliant Therapeutics, Inc.
3.4400
+5.52%
PRME Prime Medicine, Inc.
2.5200
+4.13%
SGMT Sagimet Biosciences Inc.
3.7150
+2.91%